EYEPOINT INC (EYPT) — insider trading
Health Care · NASDAQ
EYEPOINT INC (EYPT) has 38 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 5 open-market sales among the most recent 38 (latest 2026-07-10).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | Duker Jay S. | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 16,667 | $0.00 | $0 | Form 4 |
| 2026-07-10 | Duker Jay S. | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 8,059 | $14.72 | $118.6K | Form 4 |
| 2026-07-10 | Duker Jay S. | Director, Officer (President and CEO) | Option exercise / conversion | 16,667 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,438 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,437 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Open-market sale | 2,438 | $15.02 | $36.6K | Form 4 |
| 2026-06-30 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Open-market sale | 2,437 | $15.00 | $36.6K | Form 4 |
| 2026-06-30 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion | 2,438 | $8.26 | $20.1K | Form 4 |
| 2026-06-30 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion | 2,437 | $8.26 | $20.1K | Form 4 |
| 2026-05-25 | Elston George | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 7,500 | $0.00 | $0 | Form 4 |
| 2026-05-25 | Elston George | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 3,627 | $12.93 | $46.9K | Form 4 |
| 2026-05-25 | Elston George | Officer (Chief Financial Officer) | Option exercise / conversion | 7,500 | $0.00 | $0 | Form 4 |
| 2026-04-17 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,437 | $0.00 | $0 | Form 4 |
| 2026-04-17 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Open-market sale | 2,437 | $15.00 | $36.6K | Form 4 |
| 2026-04-17 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion | 2,437 | $8.26 | $20.1K | Form 4 |
| 2026-03-23 | Duker Jay S. | Director, Officer (President and CEO) | Other acquisition or disposition (derivative) | 97,500 | $9.57 | $933.1K | Form 4 |
| 2026-03-23 | Duker Jay S. | Director, Officer (President and CEO) | Other acquisition or disposition (derivative) | 97,500 | $9.57 | $933.1K | Form 4 |
| 2026-03-23 | Duker Jay S. | Director, Officer (President and CEO) | Other acquisition or disposition (derivative) | 52,500 | $8.75 | $459.4K | Form 4 |
| 2026-03-23 | Duker Jay S. | Director, Officer (President and CEO) | Other acquisition or disposition (derivative) | 52,500 | $8.75 | $459.4K | Form 4 |
| 2026-03-23 | Duker Jay S. | Director, Officer (President and CEO) | Other acquisition or disposition | 76,766 | $13.11 | $1.01M | Form 4 |
| 2026-03-23 | Duker Jay S. | Director, Officer (President and CEO) | Other acquisition or disposition | 76,766 | $13.11 | $1.01M | Form 4 |
| 2026-03-16 | Duker Jay S. | Director, Officer (President and CEO) | Open-market purchase | 1,500 | $13.15 | $19.7K | Form 4 |
| 2026-03-04 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,438 | $0.00 | $0 | Form 4 |
| 2026-03-04 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Open-market sale | 2,438 | $17.87 | $43.6K | Form 4 |
| 2026-03-04 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion | 2,438 | $8.26 | $20.1K | Form 4 |
| 2026-03-02 | Elston George | Officer (Chief Financial Officer) | Bona fide gift | 5,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Elston George | Officer (Chief Financial Officer) | Bona fide gift | 5,000 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,437 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Open-market sale | 2,437 | $15.00 | $36.6K | Form 4 |
| 2026-02-17 | Ribeiro Ramiro | Officer (Chief Medical Officer) | Option exercise / conversion | 2,437 | $8.26 | $20.1K | Form 4 |
| 2026-01-06 | Elston George | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 15,285 | $0.00 | $0 | Form 4 |
| 2026-01-06 | Elston George | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 4,487 | $16.86 | $75.7K | Form 4 |
| 2026-01-06 | Elston George | Officer (Chief Financial Officer) | Option exercise / conversion | 15,285 | $0.00 | $0 | Form 4 |
| 2026-01-06 | Duker Jay S. | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 20,793 | $0.00 | $0 | Form 4 |
| 2026-01-06 | Duker Jay S. | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 10,054 | $16.86 | $169.5K | Form 4 |
| 2026-01-06 | Duker Jay S. | Director, Officer (President and CEO) | Option exercise / conversion | 20,793 | $0.00 | $0 | Form 4 |
| 2026-01-06 | Lurker Nancy | Director | Option exercise / conversion (derivative) | 75,133 | $0.00 | $0 | Form 4 |
| 2026-01-06 | Lurker Nancy | Director | Option exercise / conversion | 75,133 | $0.00 | $0 | Form 4 |
Ask the chat about EYPT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: EYEPOINT INC (EYPT).
Last updated 2026-07-10 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.